MedPlus subsidiary hit with three store suspension over regulatory violations

July 15, 2025
Uncategorized

Optival Health Solutions, a MedPlus subsidiary, faces drug license suspensions for three outlets in Karnataka and Telangana, leading to revenue losses. MedPlus shares rose by 3.63% to ₹911.00 on the NSE.

MedPlus subsidiary hit with three store suspension over regulatory violations

Leave a ReplyCancel Reply

Stock to watch on February 16: IRB Infra, Torrent Pharma, Ola Electric, NBCC and more

Trade Setup for February 16: Nifty breaches key moving averages; downside risk toward 25,000 looms

Margin ͏trading made safer͏:͏ Understanding HDFC SKY’s 4x leverage model

SEBI looks to curb volatility in Gold and Silver ETFs, proposes to review price band

Manappuram Finance gets RBI’s conditional nod for proposed stake sale to Bain Capital